News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Daily News Take Heed of Sex Differences in Peripheral Vascular Disease: AHA Michael O'Riordan March 13, 2025
News Daily News As More Peripheral Interventions Go Radial, the AHA Offers Some Insights L.A. McKeown December 12, 2024
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News Amputation Risks Higher After Revascularization in Younger vs Older PAD Patients L.A. McKeown July 24, 2024
News Daily News BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI L.A. McKeown April 24, 2024
News Conference News CRT 2024 CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care L.A. McKeown March 20, 2024
News Conference News ISET 2024 How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy Caitlin E. Cox January 24, 2024
News Daily News New Scientific Statement Focuses on Below-the-Knee Technical Challenges L.A. McKeown January 19, 2024
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Daily News AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD L.A. McKeown October 06, 2023